ArticleAMB Express2026
Effects of dietary zinc fulvate supplementation on egg quality, serum biochemical indices, and intestinal health of aged laying hens.
Article in AMB Express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Zinc fulvate (ZFA), a chelate of fulvic acid and zinc, exhibits superior bioavailability and multifunctional properties that benefit animal health. This study aimed to evaluate the effects of dietary ZFA supplementation at different levels on egg quality, serum biochemical indices, intestinal morphology, and cecal microbiota composition in aged laying hens. A total of 480 Hy-Line Gray laying hens (63 weeks old) were randomly assigned to four groups with eight replicates each (15 hens per replicate): a control group (CON) fed a basal diet, and three experimental groups supplemented with 600 mg/kg (ZFA 600), 1200 mg/kg (ZFA 1200), and 1800 mg/kg (ZFA 1800) of ZFA, respectively. The experiment lasted for 8 weeks after a 2 weeks adaptation period. The results revealed that: (1) Compared with the CON group, ZFA 600 and ZFA 1200 groups significantly increased eggshell thickness and strength (p < 0.05). (2) ZFA 1200 group had significantly higher serum copper-zinc superoxide dismutase (CuZn-SOD) activity and lower malondialdehyde (MDA) content (p < 0.05), while ZFA 600, ZFA 1200, and ZFA 1800 groups all showed elevated serum albumin (ALB) levels (p < 0.05). (3) ZFA 600 group significantly increased villus height (VH) in the duodenum, jejunum, and ileum, as well as the villus height-to-crypt depth ratio (VH/CD) in the duodenum and jejunum (p < 0.05), while ZFA 1200 group reduced crypt depth (CD) in the duodenum and jejunum (p < 0.05). (4) At the microbial level, ZFA 600 group significantly improved the Simpson and Shannon indices of cecal microbiota (p < 0.05), and increased the relative abundances of beneficial taxa including Firmicutes (Firmicutes_A, Firmicutes_B, Firmicutes_D), Actinobacteriota, Verrucomicrobiota at the phylum level, and Mediterraneibacter_A and Prevotella at the genus level (p < 0.05). Collectively, dietary ZFA supplementation improves eggshell quality, enhances antioxidant capacity, optimizes intestinal morphology, and modulates gut microbiota homeostasis in aged laying hens. Different ZFA doses have distinct advantage targets, and the suitable dose can be selected according to actual breeding needs, e.g., 600 mg/kg ZFA can be used as a recommended addition dose for balancing the overall cecal health of laying hens, while 1200 mg/kg ZFA is suitable for scenarios requiring focused alleviation of oxidative stress. Under the conditions of this study, 600 mg/kg ZFA is recommended as the optimal supplemental level based on overall beneficial effects and physiological rationality. However, the potential risk of excessive zinc intake at high ZFA doses was not fully considered in the present study, and lower doses of ZFA should be further evaluated in future research to meet nutritional standards more precisely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.